Chemical: GCIL & GCWL: 3QFY25 Corporate Briefing Takeaways - By Taurus Research
May 16 2025
Taurus Securities
- GCIL is a key player in Pakistan’s industrial gases and chemicals sector. The Company primarily manufactures medical and industrial gases, along with bulk chemicals including sulfuric acid and allied products. Its operations cater to a range of critical sectors including healthcare, textiles, steel, and pharmaceuticals.
- The Company’s net revenue stood at PKR 1,668Mn, a 41% YoY increase from PKR 1,181Mn in 3QFY24. Consequently, gross profit margin rose to 60.8% from 25.8% in the same quarter last year. Net profit after tax (PAT) increased significantly by ~1.45x YoY, reaching PKR 514Mn compared to PKR 210Mn in 3QFY24. EPS for the quarter stood at PKR 1.03, up from PKR 0.42 in the same period last year.
- Management indicated that solar systems and batteries are currently being deployed across all plants, with the long-term goal of achieving 10MW in solar capacity. For context, the company’s total power demand is 30MW.
- GCWL is a newly incorporated public limited company, established on July 31, 2024, as a wholly owned subsidiary of Ghani Chemical Industries Limited (GCIL). The Company was created to house the Calcium Carbide Project carved out of GCIL under a demerger scheme sanctioned in February 2025. Positioned in the Hattar Special Economic Zone, GCWL will focus on import substitution through domestic production of calcium carbide and related products. The Company was successfully listed on the Pakistan Stock Exchange on April 24, 2025, and is now a standalone entity with a focused mandate in chemicals.